Shah A - Search Results

1

BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.

Ljung R, Kenet G, Mancuso ME, Kaleva V, Rusen L, Tseneklidou-Stoeter D, Michaels LA, Shah A, Hong W, Maas Enriquez M; investigators of the LEOPOLD Kids Trial. Ljung R, et al. Among authors: shah a. Haemophilia. 2016 May;22(3):354-60. doi: 10.1111/hae.12866. Epub 2015 Dec 9. Haemophilia. 2016. PMID: 26663410 Clinical Trial.

2

Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A.

Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. Coyle TE, et al. Among authors: shah a. J Thromb Haemost. 2014 Apr;12(4):488-96. doi: 10.1111/jth.12506. J Thromb Haemost. 2014. PMID: 24843882 Free PMC article. Clinical Trial.

3

Pharmacokinetic properties of BAY 81-8973, a full-length recombinant factor VIII.

Shah A, Delesen H, Garger S, Lalezari S. Shah A, et al. Haemophilia. 2015 Nov;21(6):766-71. doi: 10.1111/hae.12691. Epub 2015 May 8. Haemophilia. 2015. PMID: 25952661 Clinical Trial.

4

Improved Pharmacokinetics with BAY 81-8973 Versus Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method: A Randomized Pharmacokinetic Study in Patients with Severe Hemophilia A.

Shah A, Solms A, Garmann D, Katterle Y, Avramova V, Simeonov S, Lissitchkov T. Shah A, et al. Clin Pharmacokinet. 2017 Sep;56(9):1045-1055. doi: 10.1007/s40262-016-0492-2. Clin Pharmacokinet. 2017. PMID: 28005225 Free PMC article. Clinical Trial.

5

Population pharmacokinetic characterization of BAY 81-8973, a full-length recombinant factor VIII: lessons learned - importance of including samples with factor VIII levels below the quantitation limit.

Garmann D, McLeay S, Shah A, Vis P, Maas Enriquez M, Ploeger BA. Garmann D, et al. Among authors: shah a. Haemophilia. 2017 Jul;23(4):528-537. doi: 10.1111/hae.13192. Epub 2017 Feb 20. Haemophilia. 2017. PMID: 28220555

6

BAY 94-9027, a PEGylated recombinant factor VIII, exhibits a prolonged half-life and higher area under the curve in patients with severe haemophilia A: Comprehensive pharmacokinetic assessment from clinical studies.

Shah A, Coyle T, Lalezari S, Fischer K, Kohlstaedde B, Delesen H, Radke S, Michaels LA. Shah A, et al. Haemophilia. 2018 Sep;24(5):733-740. doi: 10.1111/hae.13561. Epub 2018 Jul 2. Haemophilia. 2018. PMID: 29963724

7

Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.

Shah A, Solms A, Wiegmann S, Ahsman M, Berntorp E, Tiede A, Iorio A, Mancuso ME, Zhivkov T, Lissitchkov T. Shah A, et al. Ann Hematol. 2019 Sep;98(9):2035-2044. doi: 10.1007/s00277-019-03747-2. Epub 2019 Jun 24. Ann Hematol. 2019. PMID: 31236667 Free PMC article. Clinical Trial.

8

Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach.

Solms A, Iorio A, Ahsman MJ, Vis P, Shah A, Berntorp E, Garmann D. Solms A, et al. Among authors: shah a. Clin Pharmacokinet. 2020 May;59(5):605-616. doi: 10.1007/s40262-019-00832-7. Clin Pharmacokinet. 2020. PMID: 31749076 Free PMC article.

9

Population pharmacokinetic (PopPK) modelling indicates that patients switching to BAY 81-8973 from rFVIII-FS can continue their dosing schedule with improved protection.

Solms A, Lalezari S, Shah A, Kenet G. Solms A, et al. Among authors: shah a. Haemophilia. 2020 May;26(3):e145-e147. doi: 10.1111/hae.13973. Epub 2020 Apr 16. Haemophilia. 2020. PMID: 32301248 Free PMC article. Clinical Trial. No abstract available.

10

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A.

Solms A, Shah A, Berntorp E, Tiede A, Iorio A, Linardi C, Ahsman M, Mancuso ME, Zhivkov T, Lissitchkov T. Solms A, et al. Among authors: shah a. Ann Hematol. 2020 Nov;99(11):2689-2698. doi: 10.1007/s00277-020-04280-3. Epub 2020 Sep 24. Ann Hematol. 2020. PMID: 32974838 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,805 results

Search Page

Filters